Analytical Data
-
Gene name
OFX
- Application
-
Alternative Names
OFX；Baf190a；Brg1；Snf2b；Transcription activator BRG1
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P51532
-
Expression Region
700-1246aa
-
AA Sequence
EVDARHIIENAKQDVDDEYGVSQALARGLQSYYAVAHAVTERVDKQSALMVNGVLKQYQIKGLEWLVSLYNNNLNGILADEMGLGKTIQTIALITYLMEHKRINGPFLIIVPLSTLSNWAYEFDKWAPSVVKVSYKGSPAARRAFVPQLRSGKFNVLLTTYEYIIKDKHILAKIRWKYMIVDEGHRMKNHHCKLTQVLNTHYVAPRRLLLTGTPLQNKLPELWALLNFLLPTIFKSCSTFEQWFNAPFAMTGEKVDLNEEETILIIRRLHKVLRPFLLRRLKKEVEAQLPEKVEYVIKCDMSALQRVLYRHMQAKGVLLTDGSEKDKKGKGGTKTLMNTIMQLRKICNHPYMFQHIEESFSEHLGFTGGIVQGLDLYRASGKFELLDRILPKLRATNHKVLLFCQMTSLMTIMEDYFAYRGFKYLRLDGTTKAEDRGMLLKTFNEPGSEYFIFLLSTRAGGLGLNLQSADTVIIFDSDWNPHQDLQAQDRAHRIGQQNEVRVLRLCTVNSVEEKILAAAKYKLNVDQKVIQAGMFDQKSSSHERRAF
-
Molecular Weight
64.8 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The study of OFX (Oxidative Stress Factor X) recombinant proteins has gained significant attention in recent years due to their potential implications in various biomedical fields, particularly in understanding oxidative stress-related diseases. Oxidative stress, resulting from an imbalance between reactive oxygen species production and antioxidant defenses, is implicated in numerous pathologies, including cancer, neurodegenerative disorders, and cardiovascular diseases. OFX has been identified as a pivotal player in cellular responses to oxidative stress, influencing cell survival, apoptosis, and inflammation. By generating recombinant OFX proteins, researchers aim to elucidate the molecular mechanisms underlying OFX's role in oxidative stress management and to assess its potential as a therapeutic target. The production of these proteins facilitates high-throughput screening of potential drug candidates and enhances our understanding of OFX's interactions with various cellular pathways. Furthermore, studying OFX recombinant proteins could lead to the identification of biomarkers for early diagnosis of oxidative stress-related conditions, ultimately paving the way for novel therapeutic strategies to mitigate the adverse effects of oxidative damage in human health. As the field of oxidative stress research continues to evolve, the insights gained from the investigation of OFX recombinant proteins hold promise for advancing our knowledge and developing innovative approaches to combat diseases associated with oxidative stress.
